NCT06316804

Brief Summary

Major depressive and anxiety disorders are highly prevalent in the general population and are a leading cause of disability. Black adults have a high burden of depression and anxiety. This study aims to assess a self- administered video-based intervention to reduce mental illness stigma and medical mistrust among Black adults with moderate to severe depression or anxiety.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
15mo left

Started Mar 2024

Longer than P75 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Mar 2024Jul 2027

First Submitted

Initial submission to the registry

February 28, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

2.4 years

First QC Date

February 28, 2024

Last Update Submit

April 15, 2026

Conditions

Keywords

StigmaDigital Mental HealthCommunity Engaged ResearchBlack AdultMobile Health

Outcome Measures

Primary Outcomes (2)

  • Treatment Inventory of Costs in Patients with Psychiatric Disorders

    An adapted version to evaluate the utilization of mental health care services. The self-report questionnaire includes single item questions that will be used such as, "How many appointments have you attended at a Mental Health Care Institution in the past 3 months? Or at another mental health treatment facility?" and "In the past 3 months, how many appointments have you had with a psychologist, psychotherapist, or psychiatrist at a hospital?". Response options are qualitative: "no appointments" or providing the number of appointments attended. The test-retest reliability based on Cohen's Kappa was 0.649. Construct validity was assessed through the number of contacts recorded in the registration data, with a high correlation (ρ = 0.791).

    12 months post intervention

  • Release of Information Form

    The release of information form will be used to objectively measure the utilization of mental healthcare services by identifying visits made to these services. More or less visits is dependent on patient needs and does not have an intrinsic positive or negative value.

    12 months post intervention

Secondary Outcomes (4)

  • Reported and Intended Behavior Scale

    Pre-intervention and up to 12 months post-intervention

  • Internalized Stigma of Mental Illness

    Pre-intervention and up to 12 months post-intervention

  • The Group Based Medical Mistrust Scale

    Pre-intervention and up to 12 months post-intervention

  • Group Help Seeking Questionnaire

    Pre-intervention and up to 12 months post-intervention

Study Arms (3)

Video Intervention 1

EXPERIMENTAL

The video intervention #1 will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). Assessments will be completed over 12 months from date of randomization.

Behavioral: Video Intervention 1

Video Intervention 2

ACTIVE COMPARATOR

The video intervention #2 will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). Assessments will be completed over 12 months from date of randomization.

Behavioral: Video Intervention 2

Waitlist Video Intervention 3

PLACEBO COMPARATOR

After the completion of the 6-month waitlist period, the experimental video intervention will be provided. The intervention will involve videos of patients describing personal narratives of mental illness, treatment and recovery, and will be delivered over 4 weeks (with two booster sessions in week 6 and 12). The intervention offered after the waitlist period will follow video intervention 1 (experimental arm).

Behavioral: Video Intervention 3

Interventions

A self-administered video-based mobile app with narratives on mental illness. The content of the videos consists of individuals sharing their personal experiences with depression and anxiety.

Video Intervention 1

A self-administered video-based mobile app with narratives on mental illness. The content of the videos consists of individuals sharing their personal experiences with depression and anxiety.

Video Intervention 2

An experimental self-administered video-based mobile app with narratives on mental illness after the waitlist period has been completed. The content of the videos consists of individuals sharing their personal experiences with depression and anxiety.

Waitlist Video Intervention 3

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • If you identify as Black American or Black immigrant
  • Experience or been diagnosed with depression and/or anxiety
  • Age 18-45 years
  • Own a smartphone with internet access
  • Have not seen a psychiatrist or therapist in the last 12 months or have not been in routine healthcare
  • English speaking

You may not qualify if:

  • Visual, hearing, voice, or motor impairments that would prevent engagement in study procedures,
  • Diagnosis of psychotic disorder or severe suicidality for which participation would be inappropriate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (5)

  • Bouwmans C, De Jong K, Timman R, Zijlstra-Vlasveld M, Van der Feltz-Cornelis C, Tan Swan S, Hakkaart-van Roijen L. Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). BMC Health Serv Res. 2013 Jun 15;13:217. doi: 10.1186/1472-6963-13-217.

    PMID: 23768141BACKGROUND
  • Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) scale: a multinational review. Compr Psychiatry. 2014 Jan;55(1):221-31. doi: 10.1016/j.comppsych.2013.06.005. Epub 2013 Sep 21.

    PMID: 24060237BACKGROUND
  • Evans-Lacko S, Rose D, Little K, Flach C, Rhydderch D, Henderson C, Thornicroft G. Development and psychometric properties of the reported and intended behaviour scale (RIBS): a stigma-related behaviour measure. Epidemiol Psychiatr Sci. 2011 Sep;20(3):263-71. doi: 10.1017/s2045796011000308.

    PMID: 21922969BACKGROUND
  • Ibrahim N, Amit N, Shahar S, Wee LH, Ismail R, Khairuddin R, Siau CS, Safien AM. Do depression literacy, mental illness beliefs and stigma influence mental health help-seeking attitude? A cross-sectional study of secondary school and university students from B40 households in Malaysia. BMC Public Health. 2019 Jun 13;19(Suppl 4):544. doi: 10.1186/s12889-019-6862-6.

    PMID: 31196033BACKGROUND
  • Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening. Prev Med. 2004 Feb;38(2):209-18. doi: 10.1016/j.ypmed.2003.09.041.

    PMID: 14715214BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepressionBehaviorStereotypingCell Phone UseSocial Stigma

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsSocial BehaviorCommunication

Study Officials

  • Aderonke Pederson, MD

    Massachuessets General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Random assignment to the 3 arms in a 1:1:1 allocation ratio will be determined centrally by the PI according to a random schedule. There is no practical way to blind the study participants to treatment and accomplish the objectives of the study. However, the study participants will be unaware of the aims of the arm to which they were assigned. Because they will not be blinded to the video exposure, the study participants assigned to one of the video contact arms will be aware that they are being exposed to a video-based contact intervention, and the study participants assigned to the waitlist control arm will be aware that they are being waitlisted. The research coordinator/team member (who will be conducting the outcome assessments) will be blinded to treatment assignment status.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three intervention arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

February 28, 2024

First Posted

March 18, 2024

Study Start

March 15, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2027

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations